05/08/2026
BloodSTOP® iX Trauma Matrix has received FDA 510(k) clearance for the external temporary treatment of severely bleeding wounds, including surgical wounds and traumatic injuries.
This clearance expands the use of Trauma Matrix in severe bleeding care across trauma, burn injuries, blast-related injuries, mass casualty response, and surgical settings.
We’re grateful to the team whose work helped make this possible, and we look forward to seeing Trauma Matrix support more clinicians, first responders, and patients across prehospital and hospital wound care.
Read the full announcement:
https://lifescienceplus.com/lifescience-plus-secures-fda-510k-clearance-for-bloodstop-ix-trauma-matrix-for-severe-bleeding-control/